🔎 Trials Near Me

Home › Femoracetabular Impingement › NCT06003101

Effect of PRP, PPP, & BMAC on Functional Outcomes Following Hip Arthroscopy for Acetabular Labral Pathologies

RecruitingPhase 3

Effect of Platelet-Rich Plasma, Platelet-Poor Plasma, & Bone Marrow Aspirate Concentrate Application on Functional Outcomes Following Hip Arthroscopy for Acetabular Labral Pathologies: A Prospective Randomized Controlled Trial

Who can join

Ages 18 and older · All sexes

Full eligibility criteria
Inclusion Criteria:

* Age: \> or equal to 18 years
* Clinically indicated for hip arthroscopy (by the study PI) to address a labral pathology
* Willingness to participate, amenable to randomization into either treatment arm of the research study, and the ability to understand \& sign the informed consent document

Exclusion Criteria:

* Non-English speaking (PROM surveys are only validated in English)
* Prior same site (i.e., ipsilateral hip) surgery, including but not limited to previous hip arthroscopy, core decompression, or periacetabular osteotomies

About the study

The goal of this clinical trial is to assess the effect of PRP/PPP/BMAC application on functional outcomes after hip arthroscopy to address acetabular labral pathologies. The main questions it aims to answer are:

1. Does PRP/PPP/BMAC application improve functional outcomes after hip arthroscopy to address acetabular labral pathologies? 2. Does PRP/PPP/BMAC application reduce the arthritic burden as measured by functional outcomes following hip arthroscopy to address labral pathologies with concomitant PRP/PPP/BMAC application?

What is being tested

Sponsor: Massachusetts General Hospital · Participants: 160 · Started: Aug 30, 2023

Contact the study team

Official record on ClinicalTrials.gov — NCT06003101

Locations in the U.S.

MassachusettsMassachusetts General Hospital, Boston

Conditions

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.